DEUTSCHE BANK AG\ - ZOMEDICA PHARMACEUTICALS COR ownership

ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 25 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ZOMEDICA PHARMACEUTICALS COR
ValueSharesWeighting
Q4 2019$0
-100.0%
2,686
-83.1%
0.00%
Q3 2019$5,000
+150.0%
15,940
+64.9%
0.00%
Q2 2019$2,000
-88.2%
9,669
-81.7%
0.00%
Q1 2019$17,000
-73.4%
52,896
-0.7%
0.00%
Q4 2018$64,000
-80.4%
53,276
-69.7%
0.00%
Q3 2018$327,000
+5.5%
175,568
+26.7%
0.00%
Q2 2018$310,000
+425.4%
138,606
+411.9%
0.00%
Q1 2018$59,00027,0790.00%
Other shareholders
ZOMEDICA PHARMACEUTICALS COR shareholders Q3 2019
NameSharesValueWeighting ↓
Cambridge Investment Research Advisors, Inc. 12,254,080$1,349,0000.01%
SABBY MANAGEMENT, LLC 470,548$52,0000.01%
jvl associates llc 58,500$6,0000.01%
WINTON GROUP Ltd 717,882$79,0000.00%
REILLY FINANCIAL ADVISORS, LLC 172,031$19,0000.00%
THOROUGHBRED FINANCIAL SERVICES, LLC 21,000$2,0000.00%
RETIREMENT INCOME SOLUTIONS, INC 32,060$3,000,0000.00%
JANE STREET GROUP, LLC 223,538$25,0000.00%
Sequoia Financial Advisors, LLC 15,000$2,0000.00%
UBS Group AG 105,639$12,0000.00%
View complete list of ZOMEDICA PHARMACEUTICALS COR shareholders